Risk of Progression to Endometrial Carcinoma in Premenopausal Women with Endometrial Hyperplasia
Critical Distinction and Management
- The presence or absence of atypia is the single most important prognostic factor, with atypia carrying a significantly higher risk of progression to carcinoma, according to the American College of Obstetricians and Gynecologists 1
Management Implications for Premenopausal Women
- Hormonal treatment options, including megestrol acetate, medroxyprogesterone, or levonorgestrel-releasing intrauterine devices, are recommended by the National Comprehensive Cancer Network 2, 3
- Close monitoring with endometrial sampling every 3-6 months is recommended during conservative management, as suggested by the National Comprehensive Cancer Network 2, 3